ask="N/A"
ask_size="N/A"
average_daily_volume="555514"
bid="N/A"
bid_size="N/A"
book_value="4.01"
change="N/A"
change_from_200_day_moving_average="-2.61"
change_from_50_day_moving_average="0.11"
change_from_52_week_high="-6.98"
change_From_52_week_low="0.37"
change_in_percent="N/A"
close="2.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.09"
eps_estimate_next_quarter="-0.45"
eps_estimate_next_year="-1.33"
ex_dividend_date="N/A"
float_shares="8428000"
high="N/A"
high_52_weeks="9.35"
last_trade_date="2/13/2017"
last_trade_price="2.37"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="2.00"
market_capitalization="36.84M"
moving_average_200_day="4.98"
moving_average_50_day="2.26"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-52.38%"
percent_change_from_50_day_moving_average="+4.85%"
percent_change_from_52_week_high="-74.65%"
percent_change_from_52_week_low="+18.50%"
previous_close="2.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.59"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.64"
stock_exchange="NGM"
symbol="NVLS"
volume="319"
weeks_range_52="2.00 - 9.35"
